Veille Scientifique

Patrice PIENKOWSKI
Coordinateur

La veille scientifique est un service proposé par la SNFGE. Elle se veut un recensement rapide et assez exhaustif des articles publiés dans les revues majeures (New England Journal of Medicine, Lancet, JAMA, Gastroenterology, Gut, Lancet Oncology, Journal of Clinical Oncology, Hepatology, Journal of Hepatology, Endoscopy, Gastrointestinal Endoscopy...).

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS

T. APARICIO
B. DENIS
A. LOPEZ
S. MANFREDI
Y. TOUCHEFEU

E. CHABRUN
A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
B. HANSLIK
JL. PAYEN
PE. RAUTOU
D. VALLA

H. DAMON
F. CORDET
T. HIGUERO
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
P. DELASALLE
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revue Titre Date Coup de coeur Thématique
Journal of Hepatology Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging nov. 18 2 ♥ Foie
Journal of Hepatology Ex vivo liver resection and autotransplantation as alternative to allotransplantation for end-stage hepatic alveolar echinococcosis nov. 18 4 ♥ Foie
Journal of Hepatology Liver transplantation in patients with multiple organ failures: Feasibility and outcomes. nov. 18 5 ♥ Foie
Journal of Hepatology Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy nov. 18 3 ♥ Foie
Journal of Hepatology Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C. nov. 18 5 ♥ Foie
Journal of Hepatology An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers. nov. 18 5 ♥ Foie
Hepatology Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen-Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis. nov. 18 4 ♥ Foie
Hepatology Ad Libitum Mediterranean and Low-Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial. nov. 18 2 ♥ Foie
Hepatology "Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients With Cirrhosis. nov. 18 4 ♥ Foie
Hepatology Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE Study. nov. 18 3 ♥ Foie
Hepatology Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study. nov. 18 4 ♥ Foie
Gastroenterology GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic FattyLiver Disease. nov. 18 4 ♥ Foie
Gastroenterology Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes nov. 18 4 ♥ Foie
Gastroenterology Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs. nov. 18 5 ♥ Foie, Carcinome hépatocellulaire (CHC)
Gut Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study. oct. 18 3 ♥ MICI
Journal of clinical oncology (JCO) Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. oct. 18 4 ♥ Cancers autres (hors CCR et CHC)
Journal of clinical oncology (JCO) CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer. oct. 18 3 ♥ Cancers autres (hors CCR et CHC)
Gut Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections. oct. 18 4 ♥ Foie (hors cancers)
Gut A novel prognostic model for transplant-free survival in primary sclerosing cholangitis. oct. 18 4 ♥ Foie (hors cancers)
The Lancet Oncology Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study. oct. 18 3 ♥ Cancers autres (hors CCR et CHC)
Digestive and Liver Disease Does the site of primary colorectal cancer influence the outcome after resection of isolated liver metastases? oct. 18 2 ♥ Cancers autres (hors CCR et CHC)
Journal of clinical oncology (JCO) Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer oct. 18 4 ♥ Pancréas/Voies biliaires
Gut Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis oct. 18 4 ♥ Pancréas/Voies biliaires
Inflammatory Bowel Diseases Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort. oct. 18 3 ♥ Coloproctologie
Gastroenterology Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders. oct. 18 4 ♥ Colo-proctologie

Pages